Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference
Resmed (NYSE: RMD) announced that chairman and CEO Mick Farrell and CFO Aaron Bloomer will participate in the 24th Annual Morgan Stanley Global Healthcare Conference in New York on September 15, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Resmed (NYSE: RMD) announced that chairman and CEO Mick Farrell and CFO Aaron Bloomer will participate in the 24th Annual Morgan Stanley Global Healthcare Conference in New York on September 15, 2026. A live, audio-only webcast of Resmed’s presentation will begin at approximately 10:00 a.m. Eastern Time, with a replay available for about 90 days via the company’s investor relations website.
Details
News Market Reaction – RMD
On Aug 28, the first trading day after this news, RMD closed 1.91% above the previous close.
Data tracked by StockTitan Argus for the Aug 28 session.
Key Figures
- Conference edition
- 24th annual
- Morgan Stanley Global Healthcare Conference
- Conference date
- September 15, 2026
- New York, NY
- Webcast start
- approximately 10:00 a.m. (Eastern Time)
- Resmed webcast presentation
- Replay availability
- approximately 24 hours
- After the live webcast ends
- Replay access period
- 90 days
- Following webcast replay availability
- Countries served
- 140 countries
- Company description
Historical Context
-
Collaboration promoted sleep-apnea awareness and highlighted CPAP treatment
-
Carol Burt became lead director ahead of Ron Taylor’s retirement
-
Revenue, margins, earnings, cash flow, and capital returns increased
-
Frazier Healthcare Partners agreed to acquire MatrixCare from Resmed
-
Resmed agreed to sell MatrixCare to Frazier Healthcare Partners
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the 24th Annual Morgan Stanley Global Healthcare Conference in New York, NY on Tuesday, September 15, 2026. Resmed’s webcast presentation will begin at approximately 10:00 a.m. (Eastern Time).
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following ninety (90) days.
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
| For investors | For media |
| +1 858.221.3304 | +1 619.510.1281 |
| investorrelations@resmed.com | news@resmed.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.